LENALIDOMIDE PLUS HIGH-DOSE VERSUS LOW-DOSE DEXAMETHASONE FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW

被引：0
作者：
Kupas, K. [1 ]
Kaspar, I. [1 ]
Baecke, V. [2 ]
Weisel, K. [3 ]
机构：
[1] Bristol Myers Squibb, Munich, Germany
[2] Ecker Ecker GmbH, Hamburg, Germany
[3] Univ Tubingen, Tubingen, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1256
引用
收藏
页码：514 / 515
页数：2
相关论文
共 50 条
  • [31] Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
    Dabkara, Deepak
    Bajpai, Jyoti
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (03) : 10 - 13
  • [32] Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma
    Kobayashi, Tsutomu
    Kuroda, Junya
    Fuchida, Shin-ichi
    Kaneko, Hitomi
    Yagi, Hideo
    Shibayama, Hirohiko
    Tanaka, Hirokazu
    Kosugi, Satoru
    Uoshima, Nobuhiko
    Kobayashi, Masayuki
    Adachi, Yoko
    Ohta, Kensuke
    Ishii, Kazuyoshi
    Uchiyama, Hitoji
    Matsuda, Mitsuhiro
    Nakatani, Eiji
    Tsudo, Mitsuru
    Shimazaki, Chihiro
    Takaori-Kondo, Akifumi
    Nomura, Shosaku
    Matsumura, Itaru
    Taniwaki, Masafumi
    Kanakura, Yuzuru
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (01) : 37 - 45
  • [33] A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raab, Marc S.
    Facon, Thierry
    Vij, Ravi
    Moreau, Philippe
    Reece, Donna E.
    White, Darrell J.
    Benboubker, Lotfi
    Zonder, Jeffrey A.
    Rossi, Jean-Francois
    Tsao, Claire
    Parli, Teresa
    Kroog, Glenn
    Singhal, Anil K.
    Richardson, Paul G.
    [J]. BLOOD, 2011, 118 (21) : 141 - 142
  • [34] A RANDOMIZED PHASE 2 STUDY OF ELOTUZUMAB WITH LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Moreau, P.
    Richardson, P.
    Jakubowiak, A.
    Jagannath, S.
    Raab, M.
    Facon, T.
    Vij, R.
    Reece, D.
    White, D.
    Benboubker, L.
    Zonder, J.
    Rossi, J. F.
    Tsao, C.
    Parli, T.
    Kroog, G.
    Singhal, A.
    Lonial, S.
    [J]. HAEMATOLOGICA, 2012, 97 : 474 - 474
  • [35] Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma: A phase I/II study
    Lonial, S.
    Vij, R.
    Harousseau, J.
    Facon, T.
    Moreau, P.
    Leleu, X.
    Westland, C.
    Singhal, A. K.
    Jagannath, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma
    Tsutomu Kobayashi
    Junya Kuroda
    Shin-ichi Fuchida
    Hitomi Kaneko
    Hideo Yagi
    Hirohiko Shibayama
    Hirokazu Tanaka
    Satoru Kosugi
    Nobuhiko Uoshima
    Masayuki Kobayashi
    Yoko Adachi
    Kensuke Ohta
    Kazuyoshi Ishii
    Hitoji Uchiyama
    Mitsuhiro Matsuda
    Eiji Nakatani
    Mitsuru Tsudo
    Chihiro Shimazaki
    Akifumi Takaori-Kondo
    Shosaku Nomura
    Itaru Matsumura
    Masafumi Taniwaki
    Yuzuru Kanakura
    [J]. International Journal of Hematology, 2015, 101 : 37 - 45
  • [37] Lenalidomide and Low-dose Dexamethasone for Treatment of Relapsed/Refractory Multiple Myeloma: Real-world Treatment Patterns from the PREAMBLE Study
    Goldschmidt, Hartmut
    Cook, Gordon
    Kuter, David
    Vij, Ravi
    Popov, Sergey
    Zyczynski, Teresa
    Davis, Catherine
    Durie, Brian
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01) : E126 - E127
  • [38] Low dose dexamethasone plus lenalidomide effective in multiple myeloma
    不详
    [J]. CANCER BIOLOGY & THERAPY, 2007, 6 (06) : 821 - 822
  • [39] Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
    San Miguel, Jesus
    Weisel, Katja
    Moreau, Philippe
    Lacy, Martha
    Song, Kevin
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Banos, Anne
    Oriol, Albert
    Alegre, Adrian
    Chen, Christine
    Cavo, Michele
    Garderet, Laurent
    Ivanova, Valentina
    Martinez-Lopez, Joaquin
    Belch, Andrew
    Palumbo, Antonio
    Schey, Stephen
    Sonneveld, Pieter
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed
    Dimopoulos, Meletios
    [J]. LANCET ONCOLOGY, 2013, 14 (11) : 1055 - 1066
  • [40] Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma
    San Miguel, Jesus F.
    Weisel, Katja C.
    Song, Kevin W.
    Delforge, Michel
    Karlin, Lionel
    Goldschmidt, Hartmut
    Moreau, Philippe
    Banos, Anne
    Oriol, Albert
    Garderet, Laurent
    Cavo, Michele
    Ivanova, Valentina
    Alegre, Adrian
    Martinez-Lopez, Joaquin
    Chen, Christine
    Renner, Christoph
    Bahlis, Nizar Jacques
    Yu, Xin
    Teasdale, Terri
    Sternas, Lars
    Jacques, Christian
    Zaki, Mohamed H.
    Dimopoulos, Meletios A.
    [J]. HAEMATOLOGICA, 2015, 100 (10) : 1334 - 1339
12345